Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16843192 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
Conditions: Type II Diabetes Mellitus;   Mixed Dyslipidemia
Interventions: Drug: fenofibrate 160 mg and placebo;   Drug: simvastatin 20 mg and placebo;   Drug: fenofibrate 160 mg and simvastatin 20 mg

Indicates status has not been verified in more than two years